Download Document 8266142

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

HIV/AIDS wikipedia , lookup

Human cytomegalovirus wikipedia , lookup

Diagnosis of HIV/AIDS wikipedia , lookup

Antiviral drug wikipedia , lookup

Microbicides for sexually transmitted diseases wikipedia , lookup

Epidemiology of HIV/AIDS wikipedia , lookup

HIV wikipedia , lookup

Transcript
Sampathkumar et al. BMC Infectious Diseases 2014, 14(Suppl 3):O2
http://www.biomedcentral.com/1471-2334/14/S3/O2
ORAL PRESENTATION
Open Access
The frequencies of naturally occurring protease
inhibitor resistance mutations in HIV proviral
sequences of drug naïve sex workers in Nairobi,
Kenya and their correlation with host immune
response driven positively selected mutations
in HIV-1
Raghavan Sampathkumar1,3, Elnaz Shadabi1,3, David La3, John Ho3, Binhua Liang1,3, Joshua Kimani1,2,
Francis A Plummer1,3, Ma Luo1,3*
From 2nd International Science Symposium on HIV and Infectious Diseases (HIV SCIENCE 2014)
Chennai, India. 30 January - 1 February 2014
Background
Sub Saharan Africa accounts for 69% of the people living
with HIV globally. Antiretroviral therapy (ART) has
saved 9 million life years in Sub Saharan Africa. However,
drug resistance mutations reduce the effectiveness of
ART, and need to be monitored for effective ART. Naturally occurring primary antiretroviral drug resistance
mutations have not been well analyzed in ART naïve
HIV+ patients from Kenya.
and 19.1% PI resistance minor mutations (34/178) among
the study subjects. D30N mutation, which occurred along
with minor mutations G48K and G73S, is known to confer high level resistance to nelfinavir. Several minor
mutations were found at five different drug resistance
sites. Positive selection analysis and correlation with disease progression revealed L10I, a PI resistance minor
mutation and a positively selected mutation driven by
host immune response, to be detrimental to host.
Methods
We examined protease inhibitor (PI) resistance mutations in ART naïve HIV-1 seropositive women from
Pumwani sex worker cohort, established in Nairobi,
Kenya, wherein HIV-1 infection is predominantly caused
by subtypes A and D viruses. We have analyzed consensus sequences of HIV protease from 234 drug naïve
patients, as a part of HIV-1 whole genome sequencing
using 454 sequencing methodology.
Conclusion
This study provides valuable data on primary drug resistance in Kenyan HIV-1 infected patients before ART
became available as well as HLA mediated immune pressure over HIV-1 protease.
Results
Analysis using HIVdb program revealed a prevalence of
0.56% of PI resistance major mutations (1/178; D30N)
* Correspondence: [email protected]
1
Department of Medical Microbiology, University of Manitoba, Winnipeg,
Manitoba, Canada
Full list of author information is available at the end of the article
Authors’ details
1
Department of Medical Microbiology, University of Manitoba, Winnipeg,
Manitoba, Canada. 2Department of Medical Microbiology, University of
Nairobi, Nairobi, Kenya. 3National Microbiology Laboratory, Public Health
Agency of Canada, Winnipeg, Manitoba, Canada.
Published: 27 May 2014
doi:10.1186/1471-2334-14-S3-O2
Cite this article as: Sampathkumar et al.: The frequencies of naturally
occurring protease inhibitor resistance mutations in HIV proviral
sequences of drug naïve sex workers in Nairobi, Kenya and their
correlation with host immune response driven positively selected
mutations in HIV-1. BMC Infectious Diseases 2014 14(Suppl 3):O2.
© 2014 Sampathkumar et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.